BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Syndax Pharmaceuticals Inc. (NASDAQ:SNDX)

2 posts

Biotech NewsSyndax (SNDX) Surges 40.5% in 3 Months

  • BioTech Health X
  • October 26, 2025
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is a clinical and now commercial-stage biopharmaceutical company committed to developing and delivering transformative…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSyndax (SNDX) Up 15% in 6 Months — Analysts See $56 High

  • BioTech Health X
  • September 17, 2025
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is a biotechnology company dedicated to developing innovative therapies that address some of the…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • ImageneBio (IMA) Targets 3,634% Upside
  • 4D Molecular Therapeutics (FDMT) Price Target Signals 176% Upside
  • Neumora Therapeutics (NMRA) Backed by Amgen with 22% Stake
  • Euda Health (EUDA) Launches Strategic India Partnership
  • Kyverna (KYTX) Could Become the 1st $10B Autoimmune CAR T Company
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • October 26, 2025
    ImageneBio (IMA) Targets 3,634% Upside
    • October 26, 2025
    4D Molecular Therapeutics (FDMT) Price Target Signals 176% Upside
    • October 26, 2025
    Neumora Therapeutics (NMRA) Backed by Amgen with 22% Stake
    • October 26, 2025
    Euda Health (EUDA) Launches Strategic India Partnership
    • October 26, 2025
    Kyverna (KYTX) Could Become the 1st $10B Autoimmune CAR T Company
Recent Posts
  • Creative Medical (CELZ) Narrows Loss by 21% and Shares Jump 14%
    • October 26, 2025
  • Gossamer Bio (GOSS) Targets $7 Billion PAH Market
    • October 26, 2025
  • Clover Health (CLOV) Surges 19% After Buy Rating
    • October 26, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (3)
  • Biotech News (509)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top